,
5 tweets,
1 min read
Read on Twitter
In October 2018 GMI reps met with DoH to discuss the Health Research Regulations. Look at the first sentence here, from this DoH memo of the meeting. 
Here’s the footnoted aside.
This is why GMI is important and needs to be tackled.
Health researchers and doctors with them are well funded and connected and make dramatic claims both about what they will achieve and what will be prevented by regulation.
Health researchers and doctors with them are well funded and connected and make dramatic claims both about what they will achieve and what will be prevented by regulation.
They are extraordinarily resistant to any perceived obstacle being put in the path of research. But the rules are there for a reason, and given the sensitivity of what they are dealing with it is not a lot to ask that they follow them.
Melodramatic claims will be made about the diseases that won’t be cured unless regulations are relaxed for them, the jobs that will be lost and so on. But do you think any other EU country would make things easier for them? Or the US?
